DNA topoisomerase II inhibitors.

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2001

Data sources: Europe PubMed Central

DNA topoisomerase II inhibitors.

descriptionPublicationkeyboard_double_arrow_right Article 18 Jan 2001 English Journal:IARC monographs on the evaluation of carcinogenic risks to humans, volume 76 (issn: 1017-1606,

Copyright policy )

pmid: 11000976

pmc: PMC7196979

DNA topoisomerase II inhibitors.

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Amsacrine, Evidence-Based Medicine, Antineoplastic Agents, Disease Models, Animal, Intestinal Absorption, Research Design, Risk Factors, Neoplasms, Carcinogens, Humans, Topoisomerase II Inhibitors, Tissue Distribution, Mitoxantrone, Etoposide, Nucleic Acid Synthesis Inhibitors, Teniposide

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	4
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average